Dgk continus

Roman name

DHC Continus

The composition and the form of

1 tablet (a proprietary system controlled release) contains digidrokodeina tartrate 60, 90 or 120 mg; in plastic bottles to 56 pcs. , in the box one bottle.

Of drugs

Analgezirutee. Waismann institute receptors in the central nervous system, activates antinozizeptivuyu system.

Farmakodinamika

Galvanic effect to the reception table 1. is a 2-4 hour and continues for 12 hours

Indications

Pain syndrome moderate and severe symptoms in rheumatoid diseases gerpeticakih liver, bone fractures, injuries, burns, malignant tumors 2nd stage; Pre - and postoperative pain.

Pregnancy and lactation

Not recommended.

Contraindications

Bronhospazm, bronchial asthma, breast-feeding (at the time of treatment should stop breastfeeding), children's age (up to 12 years).

Side-Effects

Siegenia, nausea, vomiting, decrease in appetite, headache, dizziness, and the ability to focus, urine retention.

Specific guidance

In developing constipation recommended laxatives funds.

Overdosing

Treatment includes washing the stomach with severe respiratory depression in / in, 0.4 mg naloxone, if necessary again in 2-3 min intervals.

Precautions

Be wary appoint patients receiving MAO inhibitors, high vnutricerepnam pressure, head injury. The lower dose in the elderly, patients with pechenern-pochecna deficiency gipotireozom. During treatment, it is necessary to avoid the admission of alcohol, driving, work requiring concentration.

Dosing and Administration

The inside is not liquid, in the 60-120 mg every 12 hours (maximum 240 mg / day).

Directory → Neurotropic funds → Opioids, their analogues and antagonists → Dgk continus